Market Overview:
The Europe hospital acquired disease testing market is currently witnessing robust growth. Hospital-acquired diseases (HAD), or nosocomial infections, are illnesses caused by exposure to viral, bacterial and fungal pathogens during hospital visits. Some commonly known infections are catheter-associated urinary tract infections (CAUTI), surgical site infections (SSI), hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). The various tests used to diagnose these infections are complete blood count (CBC) test, erythrocyte sedimentation rate (ESR) test, and urinalysis, cultures of the infected area, blood, urine and other body fluids. Other diagnostic tests, such as antimicrobial susceptibility testing (AST), are conducted for the testing of tuberculosis.
The increasing prevalence of hospital-acquired infections across Europe is one of the key factors driving the market. Furthermore, various technological advancements, such as the development of innovative diagnostic instruments and technologies, including flow cytometry, mass spectrometry and near-infrared spectroscopy, are providing a boost to the market growth. Additionally, the growing awareness regarding HADs and the available treatment options among patients, along with extensive research and development (R&D) in the field of medical sciences, are contributing to the growth of the market. Looking forward, IMARC Group expects the market to continue its robust growth during 2021-2026.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe hospital acquired disease testing market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region and indication.
Breakup by Indication:
- UTI (Urinary Tract Infection)
- SSI (Surgical Site Infection)
- Pneumonia
- Bloodstream Infections
- MRSA (Methicillin-Resistant Staphylococcus Aureus)
- Others
Breakup by Country:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key Questions Answered in This Report:
- How has the Europe hospital acquired disease testing market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Europe hospital acquired disease testing market?
- What are the key regional markets?
- What is the breakup of the market based on the indication?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the Europe hospital acquired disease testing market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Europe Hospital Acquired Disease Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Indication
6.1 UTI (Urinary Tract Infection)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 SSI (Surgical Site Infection)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Pneumonia
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Bloodstream Infections
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 MRSA (Methicillin-Resistant Staphylococcus Aureus)
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Country
7.1 Germany
7.1.1 Market Trends
7.1.2 Market Breakup by Indication
7.1.3 Market Forecast
7.2 France
7.2.1 Market Trends
7.2.2 Market Breakup by Indication
7.2.3 Market Forecast
7.3 United Kingdom
7.3.1 Market Trends
7.3.2 Market Breakup by Indication
7.3.3 Market Forecast
7.4 Italy
7.4.1 Market Trends
7.4.2 Market Breakup by Indication
7.4.3 Market Forecast
7.5 Spain
7.5.1 Market Trends
7.5.2 Market Breakup by Indication
7.5.3 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Breakup by Indication
7.6.3 Market Forecast
8 SWOT Analysis
8.1 Overview
8.2 Strengths
8.3 Weaknesses
8.4 Opportunities
8.5 Threats
9 Value Chain Analysis
10 Porters Five Forces Analysis
10.1 Overview
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Degree of Competition
10.5 Threat of New Entrants
10.6 Threat of Substitutes
11 Policy and Regulatory Landscape
12 Competitive Landscape
12.1 Market Structure
12.2 Key Players
12.3 Profiles of Key Players
List of Figures
Figure 1: Europe: Hospital Acquired Disease Testing Market: Major Drivers and Challenges
Figure 2: Europe: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015-2020
Figure 3: Europe: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Europe: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 5: Europe: Hospital Acquired Disease Testing Market: Breakup by Country (in %), 2020
Figure 6: Europe: Hospital Acquired Disease Testing (Urinary Tract Infection) Market: Sales Value (in Million US$), 2015 & 2020
Figure 7: Europe: Hospital Acquired Disease Testing (Urinary Tract Infection) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 8: Europe: Hospital Acquired Disease Testing (Surgical Site Infection) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Europe: Hospital Acquired Disease Testing (Surgical Site Infection) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Europe: Hospital Acquired Disease Testing (Pneumonia) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Europe: Hospital Acquired Disease Testing (Pneumonia) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Europe: Hospital Acquired Disease Testing (Bloodstream Infections) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Europe: Hospital Acquired Disease Testing (Bloodstream Infections) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Europe: Hospital Acquired Disease Testing (Methicillin-Resistant Staphylococcus Aureus) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Europe: Hospital Acquired Disease Testing (Methicillin-Resistant Staphylococcus Aureus) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Europe: Hospital Acquired Disease Testing (Other Indications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Europe: Hospital Acquired Disease Testing (Other Indications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Germany: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Germany: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 20: Germany: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: France: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: France: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 23: France: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: United Kingdom: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: United Kingdom: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 26: United Kingdom: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Italy: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Italy: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 29: Italy: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Spain: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Spain: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 32: Spain: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Others: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Others: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Europe: Hospital Acquired Disease Testing Industry: SWOT Analysis
Figure 36: Europe: Hospital Acquired Disease Testing Industry: Value Chain Analysis
Figure 37: Europe: Hospital Acquired Disease Testing Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Europe: Hospital Acquired Disease Testing Market: Key Industry Highlights, 2020 and 2026
Table 2: Europe: Hospital Acquired Disease Testing Market Forecast: Breakup by Indication (in Million US$), 2021-2026
Table 3: Europe: Hospital Acquired Disease Testing Market Forecast: Breakup by Country (in Million US$), 2021-2026
Table 4: Europe: Hospital Acquired Disease Testing Market: Competitive Structure
Table 5: Europe: Hospital Acquired Disease Testing Market: Key Players